Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
A client has prescriptions for albuterol (Proventil HFA) and salmeterol (Serevent). Which instruction should the nurse provide for this client?
A. Take albuterol first.
Take albuterol first.Taking albuterol before salmeterol does not address the potential interaction between the two medications. It is important to avoid taking them together rather than just adjusting the order of administration.
B. The order of administration does not matter
The order of administration does not matter.The order of administration does matter when it comes to medications with potential interactions. In this case, both albuterol and salmeterol are bronchodilators, and taking them together can increase the risk of adverse effects.
C. Take salmeterol first
Take salmeterol first. Similar to taking albuterol first, taking salmeterol before albuterol does not address the potential interaction between the two medications. The priority is to avoid taking them together unless specifically directed by the healthcare provider.
D. They should not be taken together.
They should not be taken together.Albuterol and salmeterol are both bronchodilators used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Albuterol is a short-acting beta agonist (SABA), typically used for quick relief of acute bronchoconstriction, while salmeterol is a long-acting beta agonist (LABA), used for long-term control and prevention of bronchospasm. Taking both medications together can increase the risk of side effects, including excessive stimulation of the beta receptors and potential cardiovascular effects. Therefore, it is important to follow healthcare provider's instructions and avoid taking albuterol and salmeterol together unless specifically directed to do so.
This question is an excerpt from Nurse Dive's nursing test bank - Ati Pharmacology II Quiz Proctored Exam. Take the full exam now
Full Explanation
A) Take albuterol first.
Taking albuterol before salmeterol does not address the potential interaction between the two medications. It is important to avoid taking them together rather than just adjusting the order of administration.
B) The order of administration does not matter.
The order of administration does matter when it comes to medications with potential interactions. In this case, both albuterol and salmeterol are bronchodilators, and taking them together can increase the risk of adverse effects.
C) Take salmeterol first.
Similar to taking albuterol first, taking salmeterol before albuterol does not address the potential interaction between the two medications. The priority is to avoid taking them together unless specifically directed by the healthcare provider.
D) They should not be taken together.
Albuterol and salmeterol are both bronchodilators used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Albuterol is a short-acting beta agonist (SABA), typically used for quick relief of acute bronchoconstriction, while salmeterol is a long-acting beta agonist (LABA), used for long-term control and prevention of bronchospasm. Taking both medications together can increase the risk of side effects, including excessive stimulation of the beta receptors and potential cardiovascular effects. Therefore, it is important to follow healthcare provider's instructions and avoid taking albuterol and salmeterol together unless specifically directed to do so.
Similar Questions
An ulcer caused by H. pylori can be successfully treated with which classification of drugs?
A. H2-receptor blockers
H2-receptor blockers:H2-receptor blockers, such as ranitidine and famotidine, are used to reduce the production of stomach acid. While they can provide symptomatic relief for ulcers by reducing acid secretion, they do not directly treat the underlying cause of the ulcer, which is the H. pylori infection.
B. Antacids
Antacids:Antacids are medications that neutralize stomach acid and can provide temporary relief from ulcer symptoms such as pain and discomfort. However, they do not eradicate the H. pylori bacteria or address the root cause of the ulcer. Antacids only provide symptomatic relief rather than treating the infection.
C. Proton-pump inhibitors
Proton-pump inhibitors: Proton-pump inhibitors (PPIs), such as omeprazole and pantoprazole, are potent acid-suppressing medications that are commonly used to treat ulcers and gastroesophageal reflux disease (GERD). While they can help in ulcer healing by reducing acid secretion and providing symptomatic relief, they are not effective in eradicating H. pylori infection. PPIs are often used in combination with antibiotics for H. pylori eradication therapy, but they are not the primary treatment on their own.
D. Antibiotics
H. pylori (Helicobacter pylori) is a bacteria that commonly infects the stomach lining and is a major cause of gastric and duodenal ulcers. Antibiotics are the primary treatment for H. pylori infection. The antibiotics kill the bacteria, allowing the ulcer to heal. Common antibiotics used to treat H. pylori include amoxicillin, clarithromycin, metronidazole, and tetracycline.
Full Explanation
A) H2-receptor blockers:
H2-receptor blockers, such as ranitidine and famotidine, are used to reduce the production of stomach acid. While they can provide symptomatic relief for ulcers by reducing acid secretion, they do not directly treat the underlying cause of the ulcer, which is the H. pylori infection.
B) Antacids:
Antacids are medications that neutralize stomach acid and can provide temporary relief from ulcer symptoms such as pain and discomfort. However, they do not eradicate the H. pylori bacteria or address the root cause of the ulcer. Antacids only provide symptomatic relief rather than treating the infection.
C) Proton-pump inhibitors:
Proton-pump inhibitors (PPIs), such as omeprazole and pantoprazole, are potent acid-suppressing medications that are commonly used to treat ulcers and gastroesophageal reflux disease (GERD). While they can help in ulcer healing by reducing acid secretion and providing symptomatic relief, they are not effective in eradicating H. pylori infection. PPIs are often used in combination with antibiotics for H. pylori eradication therapy, but they are not the primary treatment on their own.
D) Antibiotics.
H. pylori (Helicobacter pylori) is a bacteria that commonly infects the stomach lining and is a major cause of gastric and duodenal ulcers. Antibiotics are the primary treatment for H. pylori infection. The antibiotics kill the bacteria, allowing the ulcer to heal. Common antibiotics used to treat H. pylori include amoxicillin, clarithromycin, metronidazole, and tetracycline.
A nurse is caring for a client who has been taking oxymetazoline (Afrin) nasal spray for the past 10 days for allergic rhinitis. The nurse should monitor the client for which of the following manifestations as an adverse effect of this medication?
A. Sedation
Sedation:Sedation is not an adverse effect commonly associated with oxymetazoline nasal spray. Oxymetazoline works by constricting blood vessels in the nasal passages to relieve congestion and does not typically cause sedation.
B. Constipation
Constipation:Constipation is not an adverse effect associated with oxymetazoline nasal spray. Constipation is more commonly associated with medications that affect the gastrointestinal system, such as opioid analgesics or certain anticholinergic medications.
C. Productive cough
Productive cough: Productive cough is not an adverse effect commonly associated with oxymetazoline nasal spray. Productive cough refers to a cough that produces mucus or phlegm and is more often associated with respiratory infections or chronic respiratory conditions.
D. Nasal congestion
Nasal congestion.Oxymetazoline (Afrin) is a nasal decongestant spray commonly used for the temporary relief of nasal congestion associated with allergic rhinitis or the common cold. However, if oxymetazoline nasal spray is used for more than 3 to 5 consecutive days, it can lead to rebound congestion, also known as rhinitis medicamentosa. Rebound congestion occurs when the nasal mucosa becomes dependent on the medication for vasoconstriction, and upon discontinuation, nasal congestion worsens. Therefore, prolonged use of oxymetazoline nasal spray can result in a worsening of nasal congestion as an adverse effect.
Full Explanation
A) Sedation:
Sedation is not an adverse effect commonly associated with oxymetazoline nasal spray. Oxymetazoline works by constricting blood vessels in the nasal passages to relieve congestion and does not typically cause sedation.
B) Constipation:
Constipation is not an adverse effect associated with oxymetazoline nasal spray. Constipation is more commonly associated with medications that affect the gastrointestinal system, such as opioid analgesics or certain anticholinergic medications.
C) Productive cough:
Productive cough is not an adverse effect commonly associated with oxymetazoline nasal spray. Productive cough refers to a cough that produces mucus or phlegm and is more often associated with respiratory infections or chronic respiratory conditions.
D) Nasal congestion.
Oxymetazoline (Afrin) is a nasal decongestant spray commonly used for the temporary relief of nasal congestion associated with allergic rhinitis or the common cold. However, if oxymetazoline nasal spray is used for more than 3 to 5 consecutive days, it can lead to rebound congestion, also known as rhinitis medicamentosa. Rebound congestion occurs when the nasal mucosa becomes dependent on the medication for vasoconstriction, and upon discontinuation, nasal congestion worsens. Therefore, prolonged use of oxymetazoline nasal spray can result in a worsening of nasal congestion as an adverse effect.
A nurse is preparing to administer 1,000 mL of lactated Ringer's IV over 6 hr. The drop factor of the manual IV tubing is 10 gtt/mL. The nurse should set the manual IV infusion to deliver how many gtt/min? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
Full Explanation
To calculate the IV infusion rate in drops per minute (gtt/min), you can use the following formula:
IV infusion rate (gtt/min) =(Total volume (mL)×Drop factor (gtt/mL)) / Total time (min)
Given:
Total volume = 1000 mL
Drop factor = 10 gtt/mL
Total time = 6 hours = 6 hours × 60 minutes/hour = 360 minutes
Substitute the given values into the formula:
IV infusion rate (gtt/min) = (1000mL×10gtt/mL)/360 min
IV infusion rate (gtt/min) = 10,000/360
IV infusion rate (gtt/min)≈27.78gtt/min
Rounding to the nearest whole number, the IV infusion rate is approximately 28 gtt/min